Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00298116 · ClinicalTrials.gov registry record

Molecular Associations With Reproductive Failure

A clinical trial of Infertility and Spontaneous Abortions, sponsored by University of Pittsburgh.

Completed
Registry status
475
Enrollment target
1
Study location

NCT00298116 is a study of Infertility and Spontaneous Abortions that has completed, run by University of Pittsburgh. The registered enrollment target is 475 participants, below the 7,583-participant average among 74 other Infertility trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00298116, a study of Infertility and Spontaneous Abortions, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
475 participants
Enrollment target
1
Study location

Study Summary

The overall hypothesis to be tested is: women with the molecular phenotype of highly skewed X chromosome inactivation are at increased risk of spontaneous abortion.

Study Locations (1)

Pennsylvania

  • Magee-Womens Hospital - Pittsburgh

Trial Details

FieldValue
Enrollment Target 475 participants
Start Date 2000-09
Est. Completion 2008-01

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT00298116

The ClinicalTrials.gov registry entry for NCT00298116 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 475 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,583-participant average among 74 other Infertility trials with a reported enrollment target (94% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Infertility appearing as the primary indexed condition, and to 0 interventions.

NCT00298116 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00298116 about?

NCT00298116 is a clinical study titled "Molecular Associations With Reproductive Failure". The overall hypothesis to be tested is: women with the molecular phenotype of highly skewed X chromosome inactivation are at increased risk of spontaneous abortion.

What is the current status of trial NCT00298116?

This trial is currently completed. The enrollment target is 475 participants. The study started on 2000-09. Estimated completion is 2008-01.

What conditions does trial NCT00298116 study?

This clinical trial studies the following conditions: Infertility, Spontaneous Abortions.

Who is sponsoring clinical trial NCT00298116?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00298116 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infertility

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.